There are 2789 resources available
85P - Influence of different age cutoff points on the prediction of prognosis of cancer patients receiving ICIs and potential mechanistic exploration
Presenter: Qiong Lyu
Session: ePoster Display
86P - The predictive values of EPHA3 mutations for response to immune checkpoint inhibitors in solid tumors
Presenter: Zhongxing Bing
Session: ePoster Display
87P - Clinical development of a predictive biomarker with 58 tumor genes for dovitinib treatment of solid tumors
Presenter: Roberto Pili
Session: ePoster Display
88P - Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket study
Presenter: Sofie Joris
Session: ePoster Display
89P - Genomic profiling of wild-type gastrointestinal stromal tumor (GIST) reveals targetable mutations in multiple signaling pathways
Presenter: yanqiao zhang
Session: ePoster Display
139P - HER2+/HR+ breast cancer patients at high risk of relapse derive benefit from extended adjuvant treatment with neratinib: An exploratory analysis from ExteNET study
Presenter: Francesco Cognetti
Session: ePoster Display
140P - Benefit of adjuvant chemotherapy in luminal A-like early breast cancer in women aged 40 years or younger: Results of a national multi-institutional study
Presenter: Ondine Dufour
Session: ePoster Display
141P - Gene-expression pathways and dynamics during neoadjuvant chemo-free therapy predict pathologic complete response in ER+/HER2+ breast cancer (BC)
Presenter: Matteo Dugo
Session: ePoster Display
94P - ESCAT ranking of genomic alterations collected in the Italian Registry of Actionable Mutations
Presenter: Riziero Esposito Abate
Session: ePoster Display
43P - Exploring the immune contexture within tumor microenvironment in non-small cell lung carcinoma (NSCLC) by multiplex immunohistochemistry
Presenter: Chih-Hung Ye
Session: ePoster Display